Data from: NfL is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia

Hayer, Stefanie N.

Krey, Ilona

Barro, Christian

Rössler, Franziska

Körtvelyessy, Peter

Lemke, Johannes R.

Kuhle, Jens

Schöls, Ludger

Publication date: July 31, 2019

Publisher: Dryad

https://doi.org/10.5061/dryad.cm92513

Citation

Hayer, Stefanie N. et al. (2019), Data from: NfL is a biomarker for adult-onset leukoencephalopathy with axonal spheroids and pigmented glia, Dryad, Dataset, https://doi.org/10.5061/dryad.cm92513

Abstract

[No abstract entered]

Usage Notes

Hayer et al ALSP NfL Supplementary Methods

Supplementary information on procedures and statistical analyses.

Hayer et al ALSP NfL Supplementary Table S1

Demographic data of ALSP patients, mutation carriers, MS patients, and controls.

Hayer et al ALSP NfL Supplementary Figure S1

NfL in serum and/or CSF of healthy controls and presymptomatic CSF1R mutation carriers